1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients

Journal of Proteome Research

Volumn 9, Issue 9, 2010, Pages 4545-4553

  Lauridsen, Michael B ^a   Bliddal, Henning ^b,c   Christensen, Robin ^c,d   Danneskiold Samsøe, Bente ^b,c,e   Bennett, Robert ^f   Keun, Hector ^g   Lindon, John C ^g   Nicholson, Jeremy K ^g   Dorff, Mikkel H ^h   Jaroszewski, Jerzy W ⁱ   Hansen, Steen H ⁱ   Cornett, Claus ⁱ  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h FINSEN LABORATORY   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

chemometrics; disease monitoring; metabonomics; NMR; personalized medicine; phenotyping; rheumatoid arthritis

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN; LACTIC ACID; LIPID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; RHEUMATOID ARTHRITIS; AGED; BIOLOGY; BLOOD; COHORT ANALYSIS; DISEASE COURSE; METABOLISM; METABOLOME; METABOLOMICS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE; REGRESSION ANALYSIS; STATISTICAL MODEL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHENOTYPE;

EID: 77956334335     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr1002774     Document Type: Article

References (50)

1. van Jaarsveld, C. H.; Jacobs, J. W.; Schrijvers, A. J.; Heurkens, A. H.; Haanen, H. C.; Bijlsma, J. W. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study Br. J. Rheumatol. 1998, 37, 837-847
2. Albers, J. M.; Kuper, H. H.; van Riel, P. L.; Prevoo, M. L.; van't Hof, M. A.; van Gestel, A. M.; Severens, J. L. Socio-economic consequences of rheumatoid arthritis in the first years of the disease Rheumatology (Oxford) 1999, 38, 423-430
3. Goldring, M. B. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases Best Pract. Res. Clin. Rheumatol. 2006, 20, 1003-1025
4. van der Kooij, S. M.; Goekoop-Ruiterman, Y. P. M.; de Vries-Bouwstra, J. K.; Guler-Yuksel, M.; Zwinderman, A. H.; Kerstens, P. J. S. M.; van der Lubbe, P. A. H. M.; de Beus, W. M.; Grillet, B. A. M.; Ronday, H. K.; Huizinga, T. W. J.; Breedveld, F. C.; Dijkmans, B. A. C.; Allaart, C. F. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis Ann. Rheum. Dis. 2009, 68, 914-921
5. Arnett, F. C.; Edworthy, S. M.; Bloch, D. A.; Mcshane, D. J.; Fries, J. F.; Cooper, N. S.; Healey, L. A.; Kaplan, S. R.; Liang, M. H.; Luthra, H. S.; Medsger, T. A.; Mitchell, D. M.; Neustadt, D. H.; Pinals, R. S.; Schaller, J. G.; Sharp, J. T.; Wilder, R. L.; Hunder, G. G. The American-Rheumatism- Association 1987 Revised Criteria for the Classification of Rheumatoid-Arthritis Arthritis Rheum. 1988, 31, 315-324
6. Choy, E. H.; Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis N. Engl. J. Med. 2001, 344, 907-916
7. de Seny, D.; Fillet, M.; Meuwis, M. A.; Geurts, P.; Lutteri, L.; Ribbens, C.; Bours, V.; Wehenkel, L.; Piette, J.; Malaise, M.; Merville, M. P. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach Arthritis Rheum. 2005, 52, 3801-3812
8. Garnero, P.; Delmas, P. D. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers Curr. Opin.Rheumatol. 2004, 16, 428-434
9. Liao, H.; Wu, J.; Kuhn, E.; Chin, W.; Chang, B.; Jones, M. D.; O'Neil, S.; Clauser, K. R.; Karl, J.; Hasler, F.; Roubenoff, R.; Zolg, W.; Guild, B. C. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis Arthritis Rheum. 2004, 50, 3792-3803
10. Lopez-Pedrera, C.; Barbarroja, N.; Villalba, J. M. Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches Proteomics Clin. Appl. 2009, 3, 213-225
11. Meshitsuka, S.; Yamazaki, E.; Inoue, M.; Hagino, H.; Teshima, R.; Yamamoto, K. Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis Clin. Chim. Acta 1999, 281, 163-167
12. Williamson, M. P.; Humm, G.; Crisp, A. J. H-1 Nuclear Magnetic-Resonance Investigation of Synovial-Fluid Components in Osteo-Arthritis, Rheumatoid-Arthritis and Traumatic Effusions British J. Rheumatol. 1989, 28, 23-27
13. Miyata, T.; Ishiguro, N.; Yasuda, Y.; Ito, T.; Nangaku, M.; Iwata, H.; Kurokawa, K. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers Biochem. Biophys. Res. Commun. 1998, 244, 45-49
14. Naughton, D.; Whelan, M.; Smith, E. C.; Williams, R.; Blake, D. R.; Grootveld, M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy FEBS Lett. 1993, 317, 135-138
15. Claxson, A.; Grootveld, M.; Chander, C.; Earl, J.; Haycock, P.; Mantle, M.; Williams, S. R.; Silwood, C. J. L.; Blake, D. R. Examination of the metabolic status of rat air pouch inflammatory exudate by high field proton NMR spectroscopy Biochim. Biophys. Acta-Mol. Basis Dis. 1999, 1454, 57-70
16. Dursunoglu, D.; Evrenguel, H.; Polat, B.; Tanriverdi, H.; Cobankara, V.; Kaftan, A.; Kilic, M. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation Rheumatol. Int. 2005, 25, 241-245
17. McMahon, M.; Grossman, J.; FitzGerald, J.; Dahlin-Lee, E.; Wallace, D. J.; Thong, B. Y.; Badsha, H.; Kalunian, K.; Charles, C.; Navab, M.; Fogelman, A. M.; Hahn, B. H. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis Rheum. 2006, 54, 2541-2549
18. Weljie, A. M.; Dowlatabadi, R.; Miller, B. J.; Vogel, H. J.; Jirik, F. R. An Inflammatory Arthritis-Associated Metabolite Biomarker Pattern Revealed by 1H NMR Spectroscopy J. Proteome Res. 2007, 6, 3456-3464
19. Lindon, J. C.; Holmes, E.; Bollard, M. E.; Stanley, E. G.; Nicholson, J. K. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis Biomarkers 2004, 9, 1-31
20. Nicholson, J. K.; Lindon, J. C.; Holmes, E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189
21. Nicholson, J. K.; Lindon, J. C. Systems biology-Metabonomics Nature 2008, 455, 1054-1056
22. Lindon, J. C.; Nicholson, J. K.; Everett, J. R. NMR spectroscopy of biofluids Annu. Rep. NMR Spectrosc. 1999, 38, 1-88
23. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics and its role in drug development and disease diagnosis Exp. Rev. Mol. Diagn. 2004, 4, 189-199
24. Fransen, J.; Creemers, M. C. W.; Van Riel, P. L. C. M. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria Rheumatology 2004, 43, 1252-1255
25. Furst, D. E.; Keystone, E. C.; Kirkham, B.; Fleischmann, R.; Mease, P.; Breedveld, F. C.; Smolen, J. S.; Kalden, J. R.; Burmester, G. R.; Braun, J.; Emery, P.; Winthrop, K.; Bresnihan, B.; De Benedetti, F.; Doerner, T.; Gibofsky, A.; Schiff, M. H.; Sieper, J.; Singer, N.; Van Riel, P. L. C. M.; Weinblatt, M. E.; Weisman, M. H. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 Ann. Rheum. Dis. 2008, 67, 2-25
26. Tang, H.; Wang, Y.; Nicholson, J. K.; Lindon, J. C. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma Anal. Biochem. 2004, 325, 260-272
27. Nicholson, J. K.; Foxall, P. J. D.; Spraul, M.; Farrant, R. D.; Lindon, J. C. 750 MHz 1H and 1H-13C NMR Spectroscopy of Human Blood Plasma Anal. Chem. 1995, 67, 793-811
28. Ala-Korpela, M. 1H NMR spectroscopy of human blood plasma Prog. Nucl. Magn. Reson. Spectrosc. 1995, 27, 475-554
29. Ala-Korpela, M.; Lankinen, N.; Salminen, A.; Suna, T.; Soininen, P.; Laatikainen, R.; Ingman, P.; Jauhiainen, M.; Taskinen, M. R.; Heberger, K.; Kaski, K. The inherent accuracy of H-1 NMR spectroscopy to quantify plasma lipoproteins is subclass dependent Atherosclerosis 2007, 190, 352-358
30. Liu, M.; Tang, H.; Nicholson, J. K.; Lindon, J. Use of 1H NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma Magn. Reson. Chem. 2002, 40, S83-S88
31. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemometrics 2002, 16, 119-128
32. Cloarec, O.; Dumas, M. E.; Trygg, J.; Craig, A.; Barton, R. H.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. Evaluation of the Orthogonal Projection on Latent Structure Model Limitations Caused by Chemical Shift Variability and Improved Visualization of Biomarker Changes in 1H NMR Spectroscopic Metabonomic Studies Anal. Chem. 2005, 77, 517-526
33. Diggle, P. J. An Approach to the Analysis of Repeated Measurements Biometrics 1988, 44, 959-971
34. Littell, R. C.; Pendergast, J.; Natarajan, R. Modelling covariance strucutre in the analysis of repeated measures data Stat. Med. 2000, 19, 1793-1819
35. Littell, R. C.; Miliken, G. A.; Stroup, W. W.; Wolfinger, R. D.; Schabenberger, O. SAS for Mixed Models, 2 nd ed.; SAS Institute Inc: Cary, NC, 2006.
36. Landewe, R.; van der Heijde, D.; van der Linden, S.; Boers, M. Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission Ann. Rheum. Dis. 2006, 65, 637-641
37. BSRBR Control Centre Consortium; Symmons, D. P. M.; Lunt, M.; Hyrich, K. L.; Deighton, C.; Watson, K. D. on behalf of the British Society for Rheumatology Biologics Register. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity Rheumatology (Oxford) 2009, 48, 1323-1327
38. Peters, M. J. L.; Nielen, M. M. J.; Raterman, H. G.; Verheij, R. A.; Schellevis, F. G.; Nurmohamed, M. T. Increased Cardiovascular Disease in Patients with Inflammatory Arthritis in Primary Care: A Cross-sectional Observation J. Rheumatol. 2009, 36, 1866-1868
39. Schimmel, E. K.; Yazici, Y. Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience Clin. Exp. Rheum. 2009, 27, 446-451
40. Navab, M.; Anantharamaiah, G. M.; Reddy, S. T.; Van Lenten, B. J.; Ansell, B. J.; Fogelman, A. M. Mechanisms of disease: proatherogenic HDL-an evolving field Nature Clin. Pract. Endocrinol. Metab. 2006, 2, 504-511
41. Peters, M. J. L.; Vis, M.; van Halm, V. P.; Wolbink, G. J.; Voskuyl, A. E.; Lems, W. F.; Dijkmans, B. A. C.; Twisk, J. W. R.; de Koning, M. H. M. T.; van de Stadt, R. J.; Nurmohamed, M. T. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis Ann. Rheum. Dis. 2007, 66, 958-961
42. Popa, C.; van den Hoogen, F. H. J.; Radstake, T. R. D. J.; Netea, M. G.; Eijsbouts, A. E.; Den Heijer, M.; van der Meer, J. W. M.; Van Riel, P. L. C. M.; Stalenhoef, A. F. H.; Barrera, P. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis Ann. Rheum. Dis. 2007, 66, 1503-1507
43. Naughton, D. P.; Haywood, R.; Blake, D. R.; Edmonds, S.; Hawkes, G. E.; Grootveld, M. A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy FEBS Lett. 1993, 332, 221-225
44. Sattar, N.; McCarey, D. W.; Capell, H.; McInnes, I. B. Explaining How "High-Grade" Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis Circulation 2003, 108, 2957-2963
45. Parkes, H. G.; Grootveld, M. C.; Henderson, E. B.; Farrell, A.; Blake, D. R. Oxidative Damage to Synovial-Fluid from the Inflamed Rheumatoid Joint Detected by H-1-Nmr Spectroscopy J. Pharm. Biomed. Anal. 1991, 9, 75-82
46. Rudd, P. M.; Elliott, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Glycosylation and the immune system Science 2001, 291, 2370-2376
47. Georgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, D.; Drosos, A. A. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study Arthritis Res. Ther. 2006, 8, R82
48. Bakkaloglu, A.; Kirel, B.; Ozen, S.; Saatci, U.; Topaloglu, R.; Besbas, N. Plasma lipids and lipoproteins in juvenile chronic arthritis Clin. Rheumatol. 1996, 15, 341-345
49. Saag, K. G.; Teng, G. G.; Patkar, N. M.; Anuntiyo, J.; Finney, C.; Curtis, J. R.; Paulus, H. E.; Mudano, A.; Pisu, M.; Elkins-Melton, M.; Outman, R.; Allison, J. J.; Almazor, M. S.; Bridges, S. L.; Chatham, W. W.; Hochberg, M.; Maclean, C.; Mikuls, T.; Moreland, L. W.; O'Dell, J.; Turkiewicz, A. M.; Furst, D. E. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Care Res. 2008, 59, 762-784
50. Brown, A. K.; Conaghan, P. G.; Karim, Z.; Quinn, M. A.; Ikeda, K.; Peterfy, C. G.; Hensor, E.; Wakefield, R. J.; O'Connor, P. J.; Emery, P. An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis Arthritis Rheum. 2008, 58, 2958-2967